A study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Phase: 3
Status: Open-Label
About
A Randomized, Phase 3, Open-label Study to Evaluate SGN-B6A Compared With Docetaxel
in Adult Subjects With Previously Treated Non-small Cell Lung Cancer
Details
A Randomized, Phase 3, Open-label Study to Evaluate SGN-B6A Compared With Docetaxel
in Adult Subjects With Previously Treated Non-small Cell Lung Cancer
Sponsor: Seagen Inc
NCT06012435